© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

Applied Materials, Inc. (AMAT) received a crucial vote of confidence this week as Vivek Arya of BofA Securities upgraded the semiconductor equipment giant to a Buy rating on October 13, 2025. This analyst move highlights optimism about AMAT’s near- and medium-term growth prospects, underpinned by ongoing demand in chipmaking and materials engineering. Investors looking for

Following the release of the company’s impressive financial results for the second quarter that concluded on June 30, 2025, Sunrun Inc. (NASDAQ: RUN) had a notable spike in share price this morning, increasing 30.42% to $11.83. Strong Financial Results and Margin Growth Sunrun reported $569.3 million in total sales in Q2 2025, a 9% year-over-year

As of the latest check, shares of Zeta Global Holdings Corp. (NYSE: ZETA) had risen 25.58% to $19.93, marking a significant move today. The surge comes after the business revealed strong quarterly results that showed growth that led the industry and was fueled by the use of its AI-powered marketing solutions. Market Position is Strengthened

After BT Brands, Inc. (NASDAQ: BTBD) stated that it is actively investigating strategic options, the company’s stock price saw a significant increase. BTBD shares were up 145.71% as of the most recent session, trading at $4.01. BTBD Hires an Investment Banker to Conduct a Strategic Assessment BT Brands has enlisted the help of a top

American Superconductor Corporation (NASDAQ: AMSC) shares experienced a sharp rise in value when the company’s fiscal Q1 2025 results were released. As of the last market check, AMSC’s stock was up 26.24% at $55.47. The company’s first-quarter revenues of $72.4 million were a substantial increase over the $40.3 million recorded in fiscal 2024. The purchase

BioNexus Gene Lab Corp. (NASDAQ: BGLC) witnessed a sharp market rally after announcing a major partnership. As of the latest session, BGLC stock surged 45.74%, trading at $6.50. The surge follows the company’s signing of a term sheet with Singapore-based Fidelion Diagnostics Pte Ltd for a cross-equity, strategic collaboration. Both parties describe this as a

CEA Industries Inc. (NASDAQ: VAPE) experienced an extraordinary rally on Monday, with shares skyrocketing 587.94% to $61.06 following the announcement of a landmark equity development. VAPE confirmed the pricing of an oversubscribed and upsized above‑the‑market PIPE financing in partnership with 10X Capital and YZi Labs. This move positions CEA Industries to become the largest publicly

AgEagle Aerial Systems, Inc. (NYSE: UAVS) experienced a notable market rally after achieving a key federal endorsement. As of the latest session, UAVS shares were trading at $2.19, reflecting a 13.14% increase. The surge followed the announcement that its eBee VISION drone has received Blue UAS certification — a significant designation granted by the U.S.

The announcement that Veritone, Inc. (NASDAQ: VERI) has obtained “Awardable” status on the Department of Defense’s (DoD) Platform One (P1) Solutions Marketplace caused a notable market surge today, with shares surging 22.13% to $2.76. This certification expedites the procurement process for Veritone’s cutting-edge artificial intelligence products and raises the company’s profile among defense departments. Strategic

As of the latest check, Telomir Pharmaceuticals, Inc.’s (NASDAQ: TELO) stock has surged 81.40% during the morning session, trading at $2.19. This increase comes after fresh preclinical results showed that Telomir-1, the company’s primary candidate, restores epigenetic gene silencing in aggressive prostate cancer animals more successfully than the commonly used medicines Rapamycin and Paclitaxel. Restoring

Draganfly Inc. (NASDAQ: DPRO) shares surged 23.84% to trade at $4.47 as of the last check today, following the company’s announcement of a critical defense delivery order award involving its flagship drone platform. Commander3 XL Chosen by U.S. Department of Defense Draganfly (DPRO) announced that a major division of the US Department of Defense (DoD)

Monogram Technologies Inc. (NASDAQ: MGRM) shares are experiencing a substantial rally on the U.S. stock charts today, rising 73.40% to reach $5.71 at the time of last check. The dramatic surge in MGRM stock follows the announcement of a definitive merger agreement with Zimmer Biomet, under which Zimmer will acquire all outstanding shares of Monogram